Newer uses of intravenous immunoglobulins as anti-infective agents.
about
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model.Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.Antibody-based therapies as anti-infective agents.Antibody-based therapies for emerging infectious diseases.
P2860
Newer uses of intravenous immunoglobulins as anti-infective agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Newer uses of intravenous immunoglobulins as anti-infective agents.
@en
Newer uses of intravenous immunoglobulins as anti-infective agents.
@nl
type
label
Newer uses of intravenous immunoglobulins as anti-infective agents.
@en
Newer uses of intravenous immunoglobulins as anti-infective agents.
@nl
prefLabel
Newer uses of intravenous immunoglobulins as anti-infective agents.
@en
Newer uses of intravenous immunoglobulins as anti-infective agents.
@nl
P2860
P356
P1476
Newer uses of intravenous immunoglobulins as anti-infective agents.
@en
P2093
Pennington JE
P2860
P304
P356
10.1128/AAC.34.8.1463
P407
P577
1990-08-01T00:00:00Z